Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisons.
about
Experimental treatment of antipsychotic-induced movement disordersBrain Histamine N-Methyltransferase As a Possible Target of Treatment for Methamphetamine OverdoseTardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics.Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.Improvement of nonsuicidal self-injury following treatment with antipsychotics possessing strong D1 antagonistic activity: evidence from a report of three cases.Drug treatment developments in schizophrenia and bipolar mania: latest evidence and clinical usefulness.Assessing clinicians' perspectives about the identification and management of antipsychotic medication side-effects: Psychometric evaluation of a survey questionnaire.Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine ModulationPersistence of racial disparities in prescription of first-generation antipsychotics in the USA.Relating Spontaneously Reported Extrapyramidal Adverse Events to Movement Disorder Rating ScalesDopamine supersensitivity psychosis in schizophrenia: Concepts and implications in clinical practice.Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes.Post authorization safety study comparing quetiapine to risperidone and olanzapine.Revisiting Antipsychotic-induced Akathisia: Current Issues and Prospective Challenges.Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis
P2860
Q26740354-FDB6C4A6-3ACA-4BA5-BF0B-78C0A542ADD5Q28067373-AB3F5B71-FEAE-4242-BCCF-955D13DFD44AQ34388086-2B492BD2-4C83-4AE2-AF95-78C837A695ECQ34653803-DFE994FE-31E1-471C-9EEF-F6D42D195089Q35948853-2B386F9D-A973-40A4-AF5C-1D1A5EC2C3EAQ38076126-F014A129-3E14-41FD-9330-7D5AF25EC3C7Q38719003-13BFE3E9-6ADE-43CE-ACDC-8BBD6C37B616Q39041217-CD89EC78-8DF1-49CE-926F-3D11901A4FBCQ40778551-7FF5501B-88D0-4851-B757-8535535C1317Q40791623-F25839BF-4067-4F6C-BD59-0340CABBACD8Q47618934-B13D530C-58E8-4F8B-B778-42A6D879A279Q48006592-AAC63E3B-35DC-4836-83B5-E63B47B3D2A4Q48052280-F0A63375-7D04-4B86-A714-710B236EFBDAQ49460831-EDE4DFDA-4A90-4A68-93C3-A75731A1056AQ58760344-F77FFB3C-C99A-4279-9949-5A375BA2BCE4
P2860
Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisons.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Antipsychotic drugs and extrap ...... view of head-head comparisons.
@en
Antipsychotic drugs and extrap ...... view of head-head comparisons.
@nl
type
label
Antipsychotic drugs and extrap ...... view of head-head comparisons.
@en
Antipsychotic drugs and extrap ...... view of head-head comparisons.
@nl
prefLabel
Antipsychotic drugs and extrap ...... view of head-head comparisons.
@en
Antipsychotic drugs and extrap ...... view of head-head comparisons.
@nl
P2093
P2860
P356
P1476
Antipsychotic drugs and extrap ...... view of head-head comparisons.
@en
P2093
Imran B Chaudhry
Peter M Haddad
Sarvenaz Keyhani
P2860
P356
10.1177/0269881111424929
P407
P433
P577
2011-11-05T00:00:00Z